Related references
Note: Only part of the references are listed.COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Helio P. Guimaraes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients
Eva Freisinger et al.
EUROPEAN HEART JOURNAL (2020)
Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients
Eva Freisinger et al.
EUROPEAN HEART JOURNAL (2020)
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
Patricia O. Guimaraes et al.
CLINICAL CARDIOLOGY (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Classification and characteristics of on-label and off-label apixaban use in Denmark and Sweden
Nicklas Vinter et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
National Trends in Ambulatory Oral Anticoagulant Use
Geoffrey D. Barnes et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
Jonas Bjerring Olesen et al.
EUROPACE (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Race and Ethnicity Data Quality and Imputation Using US Census Data in an Integrated Health System: The Kaiser Permanente Southern California Experience
Stephen F. Derose et al.
MEDICAL CARE RESEARCH AND REVIEW (2013)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Propensity Score Techniques and the Assessment of Measured Covariate Balance to Test Causal Associations in Psychological Research
Valerie S. Harder et al.
PSYCHOLOGICAL METHODS (2010)
Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends
Jack C. J. Sun et al.
LANCET (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Death and disability from warfarin-associated intracranial and extracranial hemorrhages
Margaret C. Fang et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Doubly robust estimation in missing data and causal inference models
H Bang
BIOMETRICS (2005)
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation - An individual patient meta-analysis
C van Walraven et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Propensity score modeling strategies for the causal analysis of observational data
KH Hullsiek et al.
BIOSTATISTICS (2002)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)